6533b7d4fe1ef96bd126338c
RESEARCH PRODUCT
Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals
Lea PapstBojana BeovićCéline PulciniEmanuele Durante-mangoniJesús Rodríguez-bañoKeith S KayeGeorge L DaikosLul RakaMical PaulEsgbis EsgapL Esgie And The Crgnb Treatment Survey Study Group Collaborators: AbboP AbgueguenB AlmiranteAm AzziniF Bani-sadrM BassettiR Ben-amiB BeovićG BéraudE Botelho-neversG BouD BoutoilleA CabiéB CacopardoA CascioN CassirF CastelliM CecalaA CharmillonC ChirouzeJm CisnerosJd ColmeneroN CoppolaS CorcioneGl DaikosD Dalla GasperinaC De La Calle CabreraP DelobelD Di CaprioE Durante MangoniM DuponN EttaharMe FalagasM FalconeMc FariñasE FaureE ForestierG FotiJ GallagherG GattusoV GendrinI GentileDr GiacobbeCa GogosL Grandiere PerezY HansmannJp HorcajadaC IacobelloJt JacobJa JustoS KernéisA KomnosB Kotnik KevorkijanD LebeauxR Le BerreC LechicheV Le MoingFx LescureM LibanoreM MartinotE Merino De LucasV MondainP MondelloM MontejoJ MootienP MuñozR Nir-pazA PanJr Paño-pardoG PatelM Paul Pérez Rodríguez MtL PirothJ PogueBa PotoskiV PourcherA PyrpasopoulouG RahavM RizziJ Rodríguez-bañoM SalavertM ScheetzM SimsG SpahijaS StefaniA StefosPd TammaP TattevinA TedescoJ Torre-cisnerosP TripolitsiotiS TsiodrasG UomoR VerdonP VialeV VitratM WeinbergerY Wiener-wellsubject
0301 basic medicineAcinetobacter baumanniiCarbapenemAntibioticsDrug ResistanceDrug resistanceTigecyclineAcinetobacter baumannii; Carbapenem; Carbapenem-resistant Gram-negative bacilli; Combination therapy; Enterobacteriaceae; Polymyxin; Pseudomonas aeruginosa; SurveyPolymyxin0302 clinical medicineSurveys and Questionnairespolycyclic compounds030212 general & internal medicineAcinetobacter baumannii; Carbapenem; Carbapenem-resistant Gram-negative bacilli; Combination therapy; Enterobacteriaceae; Polymyxin; Pseudomonas aeruginosa; Survey; Anti-Bacterial Agents; Carbapenems; Cross Infection; Cross-Sectional Studies; Drug Resistance Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals; Humans; Microbial Sensitivity Tests; Surveys and QuestionnairesSurveyCarbapenemAcinetobacter baumannii; Carbapenem; Carbapenem-resistant Gram-negative bacilli; Combination therapy; Enterobacteriaceae; Polymyxin; Pseudomonas aeruginosa; Survey; Anti-Bacterial Agents; Carbapenems; Cross Infection; Cross-Sectional Studies; Drug Resistance Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals; Humans; Microbial Sensitivity Tests; Surveys and Questionnaires; Microbiology (medical); Infectious DiseasesCross InfectionbiologyMicrobial Sensitivity TestCarbapenem-resistant Gram-negative bacilliBacterialantibiotic management carbapenem-resistant Gram-negative bacteriaGeneral MedicineHospitals3. Good healthAcinetobacter baumanniiAnti-Bacterial AgentsInfectious DiseasesPseudomonas aeruginosamedicine.drugHumanMicrobiology (medical)medicine.medical_specialtymedicine.drug_class030106 microbiologyMicrobial Sensitivity TestsFosfomycincarbapenem-resistant Gram-negative bacteria03 medical and health sciencesHospitalEnterobacteriaceaeInternal medicineAnti-Bacterial AgentDrug Resistance BacterialGram-Negative BacteriamedicineGram-Negative Bacterial InfectionHumansCombination therapyCross-Sectional Studiebusiness.industrybiochemical phenomena metabolism and nutritionbiology.organism_classificationbacterial infections and mycosesCross-Sectional StudiesCarbapenemsInfectious disease (medical specialty)Carbapenem-resistant gram-negative bacilli[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieantibiotic managementbusinessGram-Negative Bacterial InfectionsRifampicindescription
ESGAP, ESGBIS, ESGIE and the CRGNB treatment survey study group.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2018-10-01 |